Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by standudu
Group name EquipeCTCS
Item Type Note
Note The following values have no corresponding Zotero field:
auth-address: APHP Tenon, IUC-UPMC, Sorbonne Universite, Alliance Pour la Recherche en Cancerologie, Paris, France; University Hospital Jean Minjoz, UMR1098, SFR IBCT, Besancon, France; Institut du Cancer Montpellier, Universite Montpellier 1, Montpellier, France; Centre Azureen de Cancerologie, Mougins, France; Centre d'Oncologie de Gentilly, Nancy, France; APHP-St. Louis, Universite Paris Diderot, Paris, France; Centre Jean-Perrin, Universite d'Auvergne, Clermont-Ferrand, France; Research Unit EA 7285, University of Versailles St-Quentin, Montigny-le-Bretonneux, France; Department of Surgery, Institut Curie, Saint-Cloud, France joseph.gligorov@tnn.aphp.fr. APHP Tenon, IUC-UPMC, Sorbonne Universite, Alliance Pour la Recherche en Cancerologie, Paris, France; University Hospital Jean Minjoz, UMR1098, SFR IBCT, Besancon, France; Institut du Cancer Montpellier, Universite Montpellier 1, Montpellier, France; Centre Azureen de Cancerologie, Mougins, France; Centre d'Oncologie de Gentilly, Nancy, France; APHP-St. Louis, Universite Paris Diderot, Paris, France; Centre Jean-Perrin, Universite d'Auvergne, Clermont-Ferrand, France; Research Unit EA 7285, University of Versailles St-Quentin, Montigny-le-Bretonneux, France; Department of Surgery, Institut Curie, Saint-Cloud, France.
alt-title: The oncologist
number: 8
accession-num: 26112003
Tags _EndnoteXML import
Date Added 2018/11/14 - 15:25:02
Date Modified 2018/11/14 - 15:25:02
Parent item Prospective Clinical Utility Study of the Use of the 21-Gene Assay in Adjuvant Clinical Decision Making in Women With Estrogen Receptor-Positive Early Invasive Breast Cancer: Results From the SWITCH Study


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés